A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria
All edits
Edits on 13 Jan, 2024
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+221 characters)
A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria
Article
Study summary
The main purpose of this study is to evaluate the long-term safety of PTC923 in participants with phenylketonuria, and to evaluate the changes from baseline in dietary phenylalanine (Phe)/protein consumption.
Infobox
Is a
NCT Number
Trial Recruitment Size
2000
Trial Sponsor
Clinical Trial Start Date
February 14, 2022
0Primary Completion Date
February 7, 2025
0Study Completion Date
February 7, 2025
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Official Website
Official Name
A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria0
Last Updated
December 8, 2023
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Find more entities like A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.